HomeStock ScreenerGland PharmaShareholding Pattern

Gland Pharma Shareholding Pattern

As of Mar 2026, Gland Pharma (GLAND) promoter holding 51.83%, FII 7.30%, DII 33.35%, public 2.53%, total shareholders 91,500. Review GLAND P/E comparison to evaluate earnings-based valuation against sector peers.

Promoter Holding 51.83%
FII Holding 7.30%
DII Holding 33.35%
Public Holding 2.53%
Total Shareholders 91,500
As of Mar 2026

GLAND Recent Shareholding Changes — Promoter, FII & DII

Gland Pharma promoter, FII and DII holding change from Dec 2025 to Mar 2026, FII -0.28%, DII +0.37%. Check GLAND market value to track the company's total market size over time.

Promoter Holding Change
Dec 2025 to Mar 2026
No Change
FII Holding Change
Dec 2025 to Mar 2026
-0.28%
DII Holding Change
Dec 2025 to Mar 2026
+0.37%
Public Holding Change
Dec 2025 to Mar 2026
-0.04%

Gland Pharma Quarterly Shareholding Trend — Promoter, FII, DII & Public

GLAND promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. For live price, key ratios and the full company profile, see GLAND screener.

Promoter
FII
DII
Public
Government

GLAND Shareholding Pattern Data — Quarterly History

Gland Pharma quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 51.83% 7.30% 33.35% 0.00% 2.53% 4.98% 99.99% 91,500
Dec 2025 51.83% 7.58% 32.98% 0.00% 2.57% 5.04% 100.00% 94,578
Sept 2025 51.83% 7.91% 32.64% 0.00% 2.57% 5.06% 100.01% 97,151
Jun 2025 51.83% 7.39% 32.85% 0.00% 2.91% 5.02% 100.00% 110,671
Mar 2025 51.83% 6.90% 33.27% 0.00% 2.99% 5.01% 100.00% 113,788
Dec 2024 51.83% 5.04% 34.80% 0.00% 3.30% 5.04% 100.01% 121,075
Sept 2024 51.83% 4.47% 35.37% 0.00% 3.28% 5.04% 99.99% 122,358
Jun 2024 51.83% 6.88% 32.83% 0.00% 3.33% 5.12% 99.99% 122,665
Mar 2024 57.86% 3.59% 25.23% 0.00% 3.28% 10.04% 100.00% 122,375
Dec 2023 57.86% 0.00% 23.14% 0.00% 3.79% 15.22% 100.01% 136,021
Sept 2023 57.86% 4.91% 22.45% 0.00% 4.52% 10.27% 100.01% 161,627
Jun 2023 57.86% 0.00% 23.38% 0.00% 5.60% 13.16% 100.00% 181,747
Mar 2023 57.86% 0.01% 23.23% 0.00% 4.26% 14.64% 100.00% 150,578
Dec 2022 57.86% 0.01% 23.13% 0.00% 4.02% 14.98% 100.00% 148,469
Sept 2022 57.86% 0.00% 20.58% 0.00% 3.77% 17.78% 99.99% 127,879
Jun 2022 57.87% 0.00% 16.71% 0.00% 3.70% 21.71% 99.99% 117,339
Mar 2022 58.00% 0.00% 11.94% 0.00% 3.69% 26.37% 100.00% 109,098
Dec 2021 58.00% 0.00% 11.21% 0.00% 3.58% 27.21% 100.00% 109,097
Sept 2021 58.02% 0.00% 11.39% 0.00% 3.77% 26.81% 99.99% 109,326
Jun 2021 58.14% 0.00% 11.57% 0.00% 3.72% 26.58% 100.01% 98,203
Mar 2021 58.25% 0.00% 10.69% 0.00% 3.30% 27.76% 100.00% 84,467
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 51.83% 7.30% 33.35% 0.00% 2.53% 4.98% 99.99% 91,500
Dec 2025 51.83% 7.58% 32.98% 0.00% 2.57% 5.04% 100.00% 94,578
Sept 2025 51.83% 7.91% 32.64% 0.00% 2.57% 5.06% 100.01% 97,151
Jun 2025 51.83% 7.39% 32.85% 0.00% 2.91% 5.02% 100.00% 110,671
Mar 2025 51.83% 6.90% 33.27% 0.00% 2.99% 5.01% 100.00% 113,788
Dec 2024 51.83% 5.04% 34.80% 0.00% 3.30% 5.04% 100.01% 121,075
Sept 2024 51.83% 4.47% 35.37% 0.00% 3.28% 5.04% 99.99% 122,358
Jun 2024 51.83% 6.88% 32.83% 0.00% 3.33% 5.12% 99.99% 122,665
Mar 2024 57.86% 3.59% 25.23% 0.00% 3.28% 10.04% 100.00% 122,375
Dec 2023 57.86% 0.00% 23.14% 0.00% 3.79% 15.22% 100.01% 136,021
Sept 2023 57.86% 4.91% 22.45% 0.00% 4.52% 10.27% 100.01% 161,627
Jun 2023 57.86% 0.00% 23.38% 0.00% 5.60% 13.16% 100.00% 181,747
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Mar 2026 51.83% 7.30% 33.35% 0.00% 2.53% 4.98% 99.99% 91,500
Dec 2025 51.83% 7.58% 32.98% 0.00% 2.57% 5.04% 100.00% 94,578
Dec 2024 51.83% 5.04% 34.80% 0.00% 3.30% 5.04% 100.01% 121,075
Dec 2023 57.86% 0.00% 23.14% 0.00% 3.79% 15.22% 100.01% 136,021
Dec 2022 57.86% 0.01% 23.13% 0.00% 4.02% 14.98% 100.00% 148,469
Dec 2021 58.00% 0.00% 11.21% 0.00% 3.58% 27.21% 100.00% 109,097